From:http://www.reuters.com/article/2015/02/02/us-diabetes-care-rising-costs-idUSKBN0L620020150202 The cost of managing diabetes has more than doubled in the past 20 years, a new analysis says. The average diabetes patient now spends $2,790 more per year than they did in 1987 and more than half the additional spending is for medications. People need to be mindful about the substantial increase in the […]
Our Blog (Page 13)
From Yahoo / AP:http://news.yahoo.com/head-fda-stepping-down-chief-scientist-over-143556691politics.html WASHINGTON (AP) From food safety to tobacco and politically charged drug approvals, Margaret Hamburg reset the course of the embattled Food and Drug Administration, an agency that had often been seen as ineffective. After nearly six years on the job, Hamburg announced her resignation Thursday in an email to staff. She […]
From:http://www.endocrinologyadvisor.com/diabetes-patients-skipping-doctors-visits/article/396176/ (HealthDay News) One in every five young American adults with diabetes has not seen a doctor in the past 6 months, according to a data brief published by the U.S. Centers for Disease Control and Preventions National Center for Health Statistics. Ongoing medical care is recommended for persons of any age who havediabetesin order […]
From:http://www.diabeteseducator.org/About/Media/02.03.15_Release For Release: February 3, 2015 A survey conducted by the American Association of Diabetes Educators (AADE) has found that suppliers selected to participate in Medicares competitive bidding program are failing to provide access to insulin pumps and related supplies. This failure to comply with the program results in limited access to necessary equipment for […]
From:http://www.medpagetoday.com/Endocrinology/Diabetes/49849 The FDA has approved the first combination pill of an SGLT2 inhibitor and a DPP-4 inhibitor, to be marketed as Glyxambi, drugmakers Eli Lilly and Boehringer Ingelheim announced. The combination of 10 or 25 mg of empagliflozin and 5 mg of linagliptin is approved as an adjunct to diet and exercise to improve glycemic […]
from:http://www.nydailynews.com/life-style/health/cell-biology-breakthrough-app-controls-diabetic-insulin-article-1.2095625 Breakthrough artificial pancreas helps control diabetics insulin levels EXCLUSIVE: For the first time, Alecia Wesner, 41, got nearly a week of good nights sleep, thanks to a revolutionary tool that regulated her insulin pump. For most of her life, Alecia Wesner has been haunted by type 1 diabetes, a disease that never lets her […]
ARIS (Reuters) Sanofi launched an inhalable insulin in the United States on Tuesday in a potential boost for its flagging diabetes drug sales and for patient quality of life. Developed by Mannkind Corp, Afrezza will be the only inhalable insulin on the U.S. market, where Sanofi competes with Eli Lilly and Novo Nordisk for sales […]
THE WHITE HOUSE Office of the Press Secretary FOR IMMEDIATE RELEASE January 30, 2015 FACT SHEET:President Obamas Precision Medicine Initiative Building on President Obamas announcement in his State of the Union Address, today the Administration is unveiling details about the Precision Medicine Initiative, a bold new research effort to revolutionize how we improve health and […]
Dapagliflozin combination improved glycemic control, reduced body weight in type 2 diabetes Matthaei S.Diabetes Care.2015;doi:10.2337/dc14-0666. Stephan Matthaei, MD,of the Diabetes-Zentrum Quakenbrck in Germany, and colleagues evaluated participants (mean age, 61 years) with an HbA1c of 7% to 10.5% receiving sulfonylurea andmetforminwho were assigned to receivedapagliflozin(Farxiga, Bristol-Myers Squibb and AstraZeneca) 10 mg/day (n=109) or placebo (n=109) […]
ADA has announced the launch of the blog series:Your Rights, One Voice (Diabetes Discrimination Stories) on the American Diabetes Association Blog: DiabetesStopsHere.org.Each month the blog will feature a different story about diabetes discrimination and how the person affected received help after contacting the American Diabetes Association (through our Legal Advocacy Program). The first story is […]